Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesCardiex Ltd

Cardiex Ltd

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.034 AUD -0.00 ( 5.56%)
Last update at 2025-09-25T00:00:00Z
VOLUME
91722
Market Cap
20.90M

Momentum Score

…

Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables, home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as CardieX Limited and changed its name to Conneqt Health Limited in September 2025. Conneqt Health Limited was founded in 1994 and is based in Sydney, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.03
Low
0.04
High
52 Week Price Range
0.03
Low
0.17
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.04
Dividend Yield
-
Revenue TTM
6.28M
Revenue Per Share
0.02
Gross Profit TTM
4.92M
Debt / Equity
1.21
ROE
-273.06%
Net Debt
3.38M
ROCE
-508.91%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -19.06M -11.38M -5.55M -3.32M -2.98M
Net income -19.06M -11.38M -5.55M -3.32M -3.04M
Selling general administrative 14.97M 11.85M 8.42M 6.62M 3.30M
Selling and marketing expenses 1.27M 1.54M 0.18M 0.43M 2.14M
Gross profit 3.70M 3.13M 4.10M 3.59M 3.10M
Reconciled depreciation - 0.22M 0.18M 0.21M 0.12M
Ebit -18.78M -11.16M -5.28M -3.16M -2.82M
Ebitda -18.71M -10.94M -5.09M -2.95M -2.71M
Depreciation and amortization 0.06M 0.22M 0.18M 0.21M 0.12M
Operating income -15.35M -12.66M -4.86M -3.67M -2.82M
Other operating expenses 24.66M 17.60M 10.66M 8.26M 7.87M
Interest expense 0.35M 0.23M 0.27M 0.16M 0.10M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.68M 0.43M 0.84M 0.13M 0.05M
Net interest income -0.09M 0.20M -0.01M -0.16M 0.06M
Income tax expense 1.05M 1.28M 0.20M 1.16M 0.06M
Total revenue 4.60M 4.07M 5.00M 4.29M 3.91M
Total operating expenses 23.43M 15.99M 9.75M 7.95M 7.07M
Cost of revenue 0.91M 0.94M 0.91M 0.70M 0.80M
Total other income expense net 0.76M 1.05M -0.07M 1.00M -0.16M
Net income from continuing ops -19.06M -11.38M -5.55M -3.32M -2.98M
Net income applicable to common shares -19.06M -11.38M -5.55M -3.32M -2.98M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 11.52M 14.30M 12.38M 11.26M 10.68M
Intangible assets - 0.63M 0.32M 0.33M 0.06M
Other current assets 1.41M 1.43M 1.57M 1.10M 0.75M
Total liab 8.32M 15.30M 5.77M 3.35M 4.80M
Total stockholder equity 3.20M -1.00M 6.61M 7.91M 5.88M
Deferred long term liab - - 0.20M 0.22M -
Other current liab 0.83M 3.55M 0.59M 0.70M 0.50M
Common stock 88.11M 76.79M 67.55M 59.29M 53.13M
Capital stock - 76.79M 67.55M 59.29M 53.13M
Retained earnings -87.56M -83.93M -65.24M -54.46M -49.22M
Other liab - 0.01M 0.00M 0.00M -
Other assets 0.00M 0.08M 0.08M 0.94M 5.02M
Cash 0.48M 0.72M 1.46M 3.67M 2.06M
Total current liabilities 7.83M 14.81M 5.12M 3.25M 3.64M
Current deferred revenue 0.31M 3.04M 0.88M 0.43M 1.52M
Net debt 3.38M 1.40M 0.61M -2.50M 0.17M
Short term debt 3.39M 1.63M 1.42M 1.04M 1.09M
Short long term debt - 1.46M 1.30M 0.99M 0.97M
Short long term debt total 3.86M 2.11M 2.07M 1.17M 2.24M
Other stockholder equity - 6.14M 0.37M -2.24M 1.97M
Property plant equipment - 1.47M 1.07M 0.35M 0.57M
Total current assets 9.27M 11.61M 4.83M 9.30M 4.69M
Long term investments - 0.51M 4.60M 3.25M 5.30M
Net tangible assets - -1.63M 5.92M 7.58M 5.82M
Short term investments 4.47M 5.56M 1.04M 1.54M 0.73M
Net receivables 0.35M 2.24M 0.81M 0.56M 0.82M
Long term debt - - - 0.00M 0.96M
Inventory 2.55M 1.66M 1.06M 0.44M 0.26M
Accounts payable 3.30M 6.59M 2.22M 1.07M 0.54M
Accumulated other comprehensive income 2.66M 6.14M 3.93M 3.09M 1.97M
Common stock total equity - - - - 53.13M
Non currrent assets other 0.66M 0.08M 0.08M 0.03M 0.06M
Non current assets total 2.25M 2.69M 7.55M 1.97M 5.98M
Capital lease obligations - 0.65M 0.77M 0.18M 0.31M
Long term debt total - 0.48M 0.65M 0.11M 1.15M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.08M -0.44M 0.36M -3.70M -2.17M
Change to liabilities 0.00M 1.60M -0.74M 0.85M -0.32M
Total cashflows from investing activities -0.08M -0.44M 0.36M -3.70M -2.17M
Net borrowings 1.97M -0.01M -0.59M 1.53M 2.45M
Total cash from financing activities 11.35M 7.41M 5.29M 2.47M 6.75M
Change to operating activities - 0.12M 0.08M -0.02M 0.23M
Net income -19.06M -12.41M -5.16M -3.32M -2.98M
Change in cash -0.74M -2.21M 1.60M -2.92M 2.24M
Begin period cash flow 1.46M 3.67M 2.06M 4.98M 2.74M
End period cash flow 0.72M 1.46M 3.67M 2.06M 4.98M
Total cash from operating activities -12.00M -9.62M -3.97M -1.70M -2.44M
Issuance of capital stock 9.91M 7.60M 6.39M 1.00M 4.50M
Depreciation - 0.32M 0.25M 0.22M 0.12M
Other cashflows from investing activities - 0.00M 0.72M -3.49M -1.92M
Dividends paid 2.98M 1.17M 0.18M 0.10M -
Change to inventory - -0.55M -0.19M -0.04M 0.22M
Change to account receivables - -0.26M -0.03M -0.02M -0.40M
Sale purchase of stock -0.54M -0.15M -0.33M -0.01M -0.25M
Other cashflows from financing activities 5.74M 2.19M -0.13M 1.73M 2.50M
Change to netincome 7.07M 2.23M 2.17M 0.63M 0.85M
Capital expenditures 0.08M 0.44M 0.36M 0.21M 0.16M
Change in working capital - -0.81M -0.21M -0.06M 0.00M
Stock based compensation 2.07M 2.11M 1.40M 0.61M -
Other non cash items 5.00M 2.47M 0.93M 1.40M 2.86M
Free cash flow -12.08M -10.06M -4.33M -1.91M -2.59M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CDX
Cardiex Ltd		 -0.00
5.56%		 0.03 - - 3.33 3.34 4.36 -2.53
COH
Cochlear Ltd		 2.26
1.50%		 152.98 68.64 27.40 4.30 5.34 3.97 28.09
IMR
Imricor Medical Systems Inc		 0.06
4.72%		 1.33 - - 36401.21 17.45 4019.33 -2.60
AVR
Anteris Technologies Global Corp		 0.50
5.88%		 9.00 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc		 -0.11
2.13%		 5.06 - 9.97 9.59 7.17 6.76 15.37

Profile*

Cardiex Ltd

Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables, home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as CardieX Limited and changed its name to Conneqt Health Limited in September 2025. Conneqt Health Limited was founded in 1994 and is based in Sydney, Australia.

55 Lime Street, Sydney, NSW, Australia, 2000

61 2 9874 8761

https://cardiex.com

Name Title Year Born
Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICD Co-Founder & Exec. Chairman 1964
Mr. Craig R. Cooper BEC, L.L.B. Co-Founder, CEO, MD & Exec. Director NA
Mr. Jarrod Travers White B.Bus, C.A., CA, CTA CFO, Joint Company Sec. & Exec. Director NA
Steve Braaten Operations Director NA
Carol Targos Accounts Mang. NA
Ahmad Qasem Chief Science & Research Officer NA
Mr. Antony Sloan Global Head of Marketing & Communications NA
Mr. ZiHan Lin VP of Corp. & Bus. Devel. NA
Ric Ruffhead Director of Sales NA
Mr. Douglas T. Kurschinski Exec. VP & Head of Global Sales for AtCor Medical Division NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

MAL
CAD 38.85
+13.53%
SOIL
CAD 8.39
+12.02%
QNC
CAD 1.48
+10.45%
TCL-B
CAD 7.26
+9.01%
CLS
CAD 345.53
+8.41%
GSY
CAD 37.75
-16.04%
BYD
CAD 109.98
-11.99%
ELE
CAD 20.12
-11.95%
LAC
CAD 2.39
-11.15%
CFW
CAD 6.51
-10.82%

Equity Sectors*

  • Basic Materials

    -1.75%

  • Communication Services

    +0.20%

  • Consumer Cyclical

    +0.18%

  • Consumer Defensive

    +0.06%

  • Energy

    +1.65%

  • Financial Services

    +0.10%

  • Healthcare

    +1.25%

  • Industrials

    +1.60%

  • Real Estate

    -0.29%

  • Technology

    +2.72%

  • Utilities

    +0.12%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…